TRT & Hormones

TRT Side Effects and How They're Managed

Myo TeamUpdated June 15, 20266 min read

TRT side effects are mostly manageable when therapy is properly monitored, but they are real and require ongoing oversight. The common ones, acne, water retention, mood shifts, and estrogen-related changes, usually respond to clinician-led adjustments in dose, frequency, or route. The side effect that most demands attention is rising hematocrit, or thicker blood, because it raises clotting risk. Management is led by your clinician and driven by regular bloodwork; this is education, not medical advice.

The Ground Rules

Two things frame everything below. First, TRT is a prescription therapy and testosterone is a Schedule III controlled substance in the US, so side-effect management happens with a licensed clinician, not solo. Second, every adjustment, whether it is a dose change, a frequency change, or anything else, is a clinical decision based on your labs and symptoms. This article explains what is common and how it is generally approached, so you know what to watch and what to bring up. It does not tell you how to dose or treat anything yourself. If you are new to TRT, TRT basics covers diagnosis and monitoring first.

The Common, Usually Manageable Side Effects

Most TRT side effects fall into a manageable category, especially once levels stabilize and the protocol is dialed in.

Acne and oily skin are common, particularly early in therapy or after a dose increase, because testosterone increases activity in the skin's sebaceous (oil) glands. It often eases as levels settle.

Water and fluid retention can show up as mild puffiness or a few pounds on the scale, frequently tied to estradiol shifts (more on that below).

Mood changes can run in either direction. Restoring testosterone often improves mood and energy in deficient men, but swings in testosterone or estradiol across the dosing interval can produce irritability or low mood for some people.

Injection-site reactions (soreness, redness, small lumps) can occur with injectable testosterone, which is part of why site rotation matters.

Hair-related changes: in men predisposed to male-pattern baldness, TRT may accelerate hair loss, since it raises the androgens involved. Responses vary widely.

None of these are guaranteed, and many improve as the protocol stabilizes.

The Estrogen Balancing Act

This one deserves its own section because it is widely misunderstood. Testosterone partly converts, or aromatizes, into estradiol (a form of estrogen), and men need some estradiol for libido, mood, bone health, and joint comfort. The goal is balance, not elimination.

Both extremes cause problems. Elevated estradiol can drive water retention, mood changes, and breast tenderness. Over-suppressed estradiol causes joint pain, low libido, and mood issues. Aggressively crushing estrogen is a common mistake that trades one set of symptoms for a worse one.

Because higher testosterone peaks tend to produce larger estradiol spikes, a frequent first move for elevated estradiol is to smooth the peaks by adjusting dose or injection frequency, rather than reaching for suppression. The conceptual link between frequency and peak size is covered in TRT dosing frequency. Estradiol is measured on a sensitive assay, and managing it is a clinician-led, lab-guided process.

The One That Most Demands Monitoring: Hematocrit

Hematocrit is the proportion of your blood made up of red blood cells, and it is the side effect that most warrants vigilance. Testosterone stimulates red blood cell production, so hematocrit commonly rises on TRT. When it climbs too high (a condition called polycythemia or erythrocytosis), the blood thickens, which raises the risk of clotting events such as stroke, deep vein thrombosis, and pulmonary embolism.

The magnitude is not trivial. A meta-analysis of 51 randomized controlled trials found testosterone therapy increased the risk of polycythemia roughly threefold versus placebo (risk ratio about 3.69; ASH Blood Advances, 2025). Endocrine Society guidance has historically advised withholding TRT if hematocrit exceeds about 54% until it normalizes, then resuming at a lower dose, while many US clinicians act earlier, often around 50 to 52%.

Management is provider-directed and can include reducing the dose, lengthening injection intervals to lower peaks, changing the route (subcutaneous may produce lower hematocrit than intramuscular for some patients), or therapeutic blood donation. The full picture is in hematocrit on TRT. This is the reason regular bloodwork on TRT is non-negotiable.

Side Effects, Causes, and How They're Generally Managed

The table below maps common effects to their likely cause and the provider-led approaches typically used. It is educational and conceptual, not a treatment plan; your clinician decides what to adjust.

Side effectLikely causeHow it's monitoredWhat's typically adjusted (provider-led)
Acne, oily skinIncreased oil-gland activitySymptom reportOften resolves as levels stabilize; sometimes dose adjustment
Water retentionEstradiol shifts, fluid balanceWeight, symptoms, estradiol labsSmooth peaks via dose or frequency change
Mood changesTestosterone/estradiol swingsSymptom tracking, labsFrequency adjustment for steadier levels
Breast tendernessElevated estradiolSensitive-assay estradiolAddress peaks; clinician-directed estradiol management
Elevated hematocritIncreased red-cell productionHematocrit/CBC on scheduleDose reduction, longer intervals, route change, phlebotomy
Fertility suppressionHPG-axis shutdownLH/FSH, historyFertility planning before starting; adjuncts under specialist care
Injection-site reactionsLocal irritationSymptom report, site checksSite rotation, technique review

The recurring theme is that management lives in the protocol and the labs, both of which are your clinician's domain.

A Note on Fertility

It belongs in any honest side-effect discussion: standard TRT suppresses the body's own testosterone and sperm production, which can impair fertility, sometimes significantly. This is dose- and duration-dependent and develops over weeks to months. For men who may want children, this is best planned before starting TRT, with a clinician, because options to preserve fertility are most effective when considered early.

When to Call Your Provider

Most side effects are managed at routine follow-ups, but some symptoms are not wait-and-see. Sudden chest pain, shortness of breath, severe headache, vision changes, or signs of a clot (such as one-sided leg swelling and pain) warrant urgent medical attention, given the hematocrit-related clotting risk. When in doubt, contact your provider or seek care.

How Tracking Makes Management Better

Side-effect management gets dramatically easier when you can show your clinician exactly what happened and when. A flare of acne three days after a dose change, a mood dip at the end of every cycle, or a slow hematocrit climb across draws are all patterns that are obvious in data and invisible in memory.

Myo, an iOS app by PixelPort LLC, logs side effects and symptoms next to your dose schedule and your lab values, so when something flares you can point to the timeline: when it started, what changed, and how it tracks with your injections. It charts trends like hematocrit and estradiol across draws so a slow climb is visible early, the kind of trendline that prompts a timely conversation. The same symptom-journaling approach is described for GLP-1 users in tracking GLP-1 side effects. Myo is a tracking and education tool only; it does not prescribe, source, or recommend doses. Your clinician manages the therapy; Myo helps you bring better data to the decision.

References

ASH Blood Advances: Drug-Induced Erythrocytosis (2025) Meta-analysis of 51 randomized trials reporting an approximately threefold increase in polycythemia risk with testosterone therapy. https://ashpublications.org/bloodadvances/article/9/9/2108/535485/Diagnosis-management-and-outcomes-of-drug-induced

Endocrine Society: Testosterone Therapy Clinical Practice Guideline Guidance on monitoring, hematocrit thresholds, estradiol considerations, and side-effect management for TRT. https://www.endocrine.org/clinical-practice-guidelines/testosterone-therapy

PMC: TRT-Induced Erythrocytosis and Therapeutic Phlebotomy (2024) Review of hematocrit elevation on TRT and management approaches including dose adjustment and phlebotomy. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11466264/

FDA Testosterone Prescribing Information (2022) Label information on adverse effects, monitoring, and controlled-substance status for injectable testosterone. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/216318s000lbl.pdf

Frequently asked questions

What are the side effects of TRT?

Common side effects include acne and oily skin, fluid or water retention, mood changes, and effects tied to estrogen shifts such as breast tenderness. Injection-site reactions can occur with injectable testosterone. The most clinically important effect is a rise in hematocrit, the proportion of red blood cells in your blood, which thickens the blood and is closely monitored. TRT also suppresses natural production and can affect fertility. Most of these are manageable under provider supervision, but they require ongoing bloodwork; this article is education, not medical advice.

How is high estrogen managed on TRT?

Testosterone converts (aromatizes) partly into estradiol, and both high and low estradiol cause problems, so the goal is balance, not elimination. High estradiol can cause water retention, mood changes, or breast tenderness, while over-suppressed estradiol causes joint pain, low libido, and mood issues. Clinicians often address elevated estradiol first by adjusting dose or injection frequency to smooth peaks, and only sometimes by other means; aggressive estrogen suppression can backfire. This is a clinician-led decision guided by sensitive-assay estradiol labs, not something to manage on your own.

Does TRT cause acne or hair loss?

TRT can cause acne and oily skin, particularly early in therapy or after dose increases, because testosterone increases activity in the skin's oil glands. In men genetically predisposed to male-pattern hair loss, TRT may accelerate that process, since it raises the androgens involved, though responses vary widely. Neither is universal. Acne often eases as levels stabilize, and your clinician can adjust the protocol; hair-loss management is a separate conversation with your provider. These are common but individual effects.

What TRT side effects are serious?

The most serious concern is elevated hematocrit (polycythemia), because thicker blood raises the risk of clotting events like stroke, deep vein thrombosis, or pulmonary embolism. A meta-analysis of 51 randomized trials found testosterone therapy increased polycythemia risk roughly threefold versus placebo (ASH Blood Advances, 2025). This is why hematocrit is monitored on a schedule and why guidelines specify thresholds for action. Any sudden severe symptoms, such as chest pain, shortness of breath, or signs of a clot, warrant urgent medical attention, not a wait-and-see approach.

How are TRT side effects reduced?

Most management is about the protocol: adjusting the dose, splitting it into more frequent smaller injections to smooth peaks and troughs, or changing the injection route, all guided by labs. For elevated hematocrit, options include dose reduction, longer intervals, route changes, or therapeutic blood donation, all provider-directed. The common thread is that reduction comes from clinician-led adjustments informed by regular bloodwork, not from self-experimentation. Tracking your symptoms over time helps your clinician see what changed and when.